You are here

Celgene Corporation

Member Since 2012

Mark J. Alles

Chief Executive Officer & Chairman

Mr. Alles serves as Celgene’s Chairman & Chief Executive Officer.  He assumed the role of Chief Executive Officer and joined Celgene’s Board of Directors on March 1, 2016.  Previously he served as President and Chief Operating Officer.  Mr. Alles served as Executive Vice President and Global Head of Hematology and Oncology from December 2012 until July 2014, following his promotion to Executive Vice President and Chief Commercial Officer in February 2012.  Mr. Alles joined Celgene in April 2004 and served as Vice President, Global Marketing until March 2009 when he became President of the Americas Region.  Responsibility for commercial operations in Japan and the Asia Pacific Region was added in July 2011.  Mr. Alles previously served as Vice President for the U.S. Oncology Business Unit of Aventis Pharmaceuticals and in other commercial sales and marketing management roles over an 11-year period with Aventis.  After earning his B.S. degree from Lock Haven University of Pennsylvania and serving as a Captain in the United States Marine Corps, Mr. Alles began his 29-year career in the pharmaceutical industry at Bayer and worked at Centocor before its acquisition by Johnson & Johnson.  Mr. Alles is a member of the Celgene Board of Directors, the Trustees for the Healthcare Institute of New Jersey (HINJ), the Board of the Biotechnology Innovation Organization (BIO), and the Board of Gilda’s Club NYC, a not-for-profit organization helping the families of people living with cancer.


CEO Cancer Gold Standard™

Gold Standard  Employer

Gold Standard Since 2014 | Global Gold Standard Employer Since 2014

Gold Standard  Task Force Participation

Task Force Subcommittee: Joel W. Beetsch, PhD, Vice President, Patient Advocacy, Corporate Affairs

Global Gold Standard  Task Force Participation

Accreditation received in 2014

Member Global Gold Standard Subcommittee: Joel W. Beetsch, PhD, Vice President, Patient Advocacy, Corporate Affairs

Life Sciences Consortium

LSC  Task Force Participation

Task Force Member(s): Joel W. Beetsch, PhD, Vice President, Patient Advocacy, Corporate Affairs; Richard H. Bagger, JD Senior Vice President, Corporate Affairs & Strategic Market Access

Project Data Sphere, LLC

an independent initiative of the Life Sciences Consortium

Data Provider

Pioneering Data Provider

Further Support

Founding Member, CEO Roundtable on Cancer - China

Celgene Corporation

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients.